Warning: Parameter 1 to keywords_appendTags() expected to be a reference, value given in /home/mydochub/public_html/blog/wp-includes/plugin.php on line 170

Related posts:

  1. Miracle of Umbilical Cord Blood
  2. California Leads in Stem-Cell Research
  3. Stem Cell Bill Likely to Be Vetoed By Bush
  4. Controversial Approach to Stem Cell Research
  5. U.K. Removes Restrictions on Egg Donation For Stem Cell Research

|



Comments

Name (required)

Email (required)

Website

Leave a comment

12 Comments so far

  1. Ron | 17 January 2008, 20:15

    A treatment made from natural plants is reported to greatly reduce the number and severity of SCD crises. It is Nicosan and is not available in the US at this time.

  2. angel | 28 February 2008, 20:41

    So where can it be found?

  3. Aslepius | 06 March 2008, 00:46

    Here is the latest on Nicosan/Niprisan a treatment for sickle cell anemia that has orphan drug status with both the FDA and E.U. The only thing holding it back is the pending investigational drug applications. It has completed phase IIb clinical trials.

    This drug could be obtained for use in the United States if a concerned group of patients would enlist the aid of a doctor to apply for the FDA’s expanded access program. It is a way for a non-toxic drug which is not approved to be made available for conditions where no approved drug is as safe. This drug shows a more than competitive success rate with none of the side effects of hydroxyurea.

    United Nations Economic Commission For Africa

    Book Of Abstracts

    Science With Africa Conference

    March 3-7, 2008

    page 30

    Evaluation of Niprisan (Herbal Medicine) for the Management of Sickle Cell
    Anaemia

    Charles Wambebe and Hadiza Khamofu, International Biomedical Research in Africa, Abuja,
    Nigeria, wambebe@yahoo.com, Joseph Okogun, Nathan Nasipuri and Karynius Gamaniel,
    National Institute for Pharmaceutical Research and Development, Abuja, Nigeria.

    About 70% of all sickle cell anemia (SCA) subjects reside in Africa, estimated at over 12 million. The prevalence of SCA is estimated at over 2% while infant mortality is about 8% and survival rate of SCA babies in rural areas by five years of age is about 20%. These statistics indicate that SCA is probably the most neglected (and sometimes forgotten by health authorities) serious public health disorder with serious mortality and morbidity rates in Africa. The objective was to undertake pre-clinical and clinical assessments of a herbal extract vis-à-vis management of sickle cell anemia using Good Laboratory Practice and Good Clinical Practice principles respectively. In Africa, there is no standard treatment for sickle cell anemia, only palliative management is generally available. In view of this situation, most
    SCA subjects use herbal medicines. NIPRISAN is a standardized extract from four medicinal/food plants: Piper guineenses seeds, Pterocarpus osun stem, Eugenia caryophyllum fruit and Sorghum bicolor leaves. Short term toxicity study indicated that NIPRISAN was safe in laboratory animals. Bio-activity guided fractionation show that vanillin and aromatic aldehydes may be the bioactive moieties. NIPRISAN reversed sickled red blood cells and
    protected them from being sickled when exposed to low oxygen tension. NIPRISAN dose- dependently delayed polymer formation of haemoglobin S. NIPRISAN induced 85% increased solubility of deoxy haemoglobin S. The in vivo efficacy study was undertaken at Children Hospital of Philadelphia, USA. Histological examination of lungs of control Tg transgenic mice carrying human sickle haemoglobin showed entrapment of massive numbers
    of sickled cells in alveolar capillaries. NIPRISAN significantly cleared the lungs of sickled cells. Furthermore, NIPRISAN induced profound effect on the survival time of Tg mice under hypoxic conditions (p

  4. Aslepius | 20 March 2008, 16:33

    United Nations Economic Commission For Africa

    Book Of Abstracts

    Science With Africa Conference

    March 3-7, 2008

    page 30

    Evaluation of Niprisan (Herbal Medicine) for the Management of Sickle Cell
    Anaemia

    Charles Wambebe and Hadiza Khamofu, International Biomedical Research in Africa, Abuja,
    Nigeria, wambebe@yahoo.com, Joseph Okogun, Nathan Nasipuri and Karynius Gamaniel,
    National Institute for Pharmaceutical Research and Development, Abuja, Nigeria.

    About 70% of all sickle cell anemia (SCA) subjects reside in Africa, estimated at over 12 million. The prevalence of SCA is estimated at over 2% while infant mortality is about 8% and survival rate of SCA babies in rural areas by five years of age is about 20%. These statistics indicate that SCA is probably the most neglected (and sometimes forgotten by health authorities) serious public health disorder with serious mortality and morbidity rates in Africa. The objective was to undertake pre-clinical and clinical assessments of a herbal extract vis-à-vis management of sickle cell anemia using Good Laboratory Practice and Good Clinical Practice principles respectively. In Africa, there is no standard treatment for sickle cell anemia, only palliative management is generally available. In view of this situation, most
    SCA subjects use herbal medicines. NIPRISAN is a standardized extract from four medicinal/food plants: Piper guineenses seeds, Pterocarpus osun stem, Eugenia caryophyllum fruit and Sorghum bicolor leaves. Short term toxicity study indicated that NIPRISAN was safe in laboratory animals. Bio-activity guided fractionation show that vanillin and aromatic aldehydes may be the bioactive moieties. NIPRISAN reversed sickled red blood cells and
    protected them from being sickled when exposed to low oxygen tension. NIPRISAN dose- dependently delayed polymer formation of haemoglobin S. NIPRISAN induced 85% increased solubility of deoxy haemoglobin S. The in vivo efficacy study was undertaken at Children Hospital of Philadelphia, USA. Histological examination of lungs of control Tg transgenic mice carrying human sickle haemoglobin showed entrapment of massive numbers
    of sickled cells in alveolar capillaries. NIPRISAN significantly cleared the lungs of sickled cells. Furthermore, NIPRISAN induced profound effect on the survival time of Tg mice under hypoxic conditions (p

  5. Ron | 14 April 2008, 19:50

    If you would like more information about this you can email me at goldrush2001 AT yahoo DOT com.

  6. pennasia normalization | 14 April 2008, 20:33

    Hello, we are pleased to find your site. We would like to have

    good sharing. For the patients or the sufferers, hopefully,

    they really get well as soon as possible. And additional

    information in a few days later, I will launch Technique of

    Diabetes Therapy for free charge in my site. You can tell your

    friends or someone that suffers diabetes about this good

    information. Good luck and God bless you!!

    Regards,

  7. Massive 70% Commission! | 7Wins.eu | 05 June 2008, 10:27

    [...] trading systems, automated trading, investments, invest Sites you may be interested in Photo Project Sheds Light on Sickle Cell Anemia at MyDocHub Blog – Online Health Community Tags stock market trade stock market investing stock market stock trading trading system day [...]

  8. smith | 18 August 2008, 06:17

    this is a very informative post, i was searching in google for anemia and came across this post my niece is suffering from chronic anemia, information mention in this article will greatly help me in offering her some advice.
    thank you
    Deborah

  9. Sickle Cell Anemia Video at MyDocHub Blog - Online Health Community | 01 February 2009, 13:46

    [...] this sickle cell video by the American College of Physicians, showing that patients with sickle cell anemia are experiencing more pain that previously thought. More severe pain to be exact, and knowing [...]

  10. Anonymous | 14 August 2009, 22:42

    I found your site on faves.com bookmarking site.. I like it ..gave it a fave for you..ill be checking back later

  11. oderas | 11 April 2011, 16:43

    we are a family who have just discoverd that our daughter who is now 12year was born with sickel cell dieases and we never knew until now.we are so worry and we ask for advice from other parents who have kids with this problem to help us understand more about its

  12. shelton | 11 April 2011, 18:17

    wat if the mother have sickle cell disease and the father have the trait wat who the baby have?